Literature DB >> 24738852

Probable transfusion-transmission of Anaplasma phagocytophilum by leukoreduced platelets.

Rebecca L Townsend1, Erin D Moritz, Lawrence B Fialkow, Victor Berardi, Susan L Stramer.   

Abstract

BACKGROUND: Anaplasma phagocytophilum (AP), a tick-borne obligate intracellular bacterium, causes human granulocytic anaplasmosis (HGA) and has been implicated in seven transfusion-transmitted (TT)-HGA cases associated with red blood cells (RBCs). Here we report the first probable case of TT-HGA involving leukoreduced platelets (PLTs). CASE REPORT: A hospitalized male received 25 blood components (November 2012) before his death from trauma. Hospital testing confirmed HGA by peripheral blood smears; samples were also sent to IMUGEN, Inc. (Norwood, MA), for AP-polymerase chain reaction (PCR) and AP-immunoglobulin (Ig)M and IgG enzyme immunoassay. All 12 potentially transmitting donors provided follow-up samples.
RESULTS: Recipient smears progressed from negative to predominantly positive 16 days posttransfusion; hospital-performed AP-PCR was positive on Day 22. IMUGEN sample testing was PCR positive and IgM and IgG negative 14 to 23 days posttransfusion. The recipient had no known AP risk factors. One of 12 donors of RBCs or PLTs (leukoreduced 5-day-old PLTs) provided six follow-up samples; all were strongly IgG positive and IgM negative; one was PCR-positive. The IgG-positive donor was a 52-year-old female from Hudson Valley, New York, an area endemic for AP. She reported tick bites in September to October 2012 with no travel outside New York. The donor remained asymptomatic and received no treatment. The cocomponent PLT unit was transfused to a 78-year-old male who died of causes unrelated to AP.
CONCLUSIONS: This eighth case of probable TT-HGA indicates that leukoreduced PLTs may be infectious. An antibody- and PCR-positive donor having prior tick exposure living in an endemic area was identified. PCR positivity and elevated IgG levels, which continue to exceed the assay's detectible range even in the absence of IgM, indicate active donor infection.
© 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24738852     DOI: 10.1111/trf.12675

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

2.  Asymptomatic "Candidatus Neoehrlichia mikurensis" infections in immunocompetent humans.

Authors:  Renata Welc-Falęciak; Edward Siński; Maciej Kowalec; Joanna Zajkowska; Sławomir A Pancewicz
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

Review 3.  Neoehrlichiosis: an emerging tick-borne zoonosis caused by Candidatus Neoehrlichia mikurensis.

Authors:  Cornelia Silaghi; Relja Beck; José A Oteo; Martin Pfeffer; Hein Sprong
Journal:  Exp Appl Acarol       Date:  2015-06-17       Impact factor: 2.132

Review 4.  Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.

Authors:  Farhan Ahmad Atif
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

Review 5.  Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens.

Authors:  K J Wardrop; A Birkenheuer; M C Blais; M B Callan; B Kohn; M R Lappin; J Sykes
Journal:  J Vet Intern Med       Date:  2016 Jan-Feb       Impact factor: 3.333

Review 6.  Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases.

Authors:  Igor Dumic; Dorde Jevtic; Mladjen Veselinovic; Charles W Nordstrom; Milan Jovanovic; Vanajakshi Mogulla; Elmira Mofid Veselinovic; Ann Hudson; Gordana Simeunovic; Emilia Petcu; Poornima Ramanan
Journal:  Microorganisms       Date:  2022-07-15

Review 7.  Opening the black box of Anaplasma phagocytophilum diversity: current situation and future perspectives.

Authors:  Thibaud Dugat; Anne-Claire Lagrée; Renaud Maillard; Henri-Jean Boulouis; Nadia Haddad
Journal:  Front Cell Infect Microbiol       Date:  2015-08-14       Impact factor: 5.293

8.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.